Physician

Sandra Nash Hannegan, MD

According to 2025 Medicare claims, Sandra Hannegan, MD (NPI: 1710076294) practices dermatology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Charleston, SC. This provider's primary affiliated billing organization is LOWCOUNTRY DERMATOLOGY ASSOCIATES (NPI: 1861518441; TIN: 570547935) and primary practice location at 29407-7779.

Hannegan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,527 traditional Medicare patients, billed 15,407 HCPCS/CPT codes, and received $838,083 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,805 prescription claims across 631 beneficiaries totaling $1,089,569 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 47 records totaling $1,098. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $311,640 to $838,083. Similarly, Part D prescription costs have moved sharply higher in recent years, from $289,971 to $1,089,569. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$440K$880K2015 Medicare payment: $311,640 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $355,122 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $382,388 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $396,034 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $410,418 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $458,243 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $808,525 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $745,163 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $879,852 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $838,083 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,56312,502$311,640
20161,64414,711$355,122
20171,78114,252$382,388
20181,75913,291$396,034
20191,78013,522$410,418
20201,65412,483$458,243
20211,79916,250$808,525
20221,95016,031$745,163
20232,25619,480$879,852
20241,52715,407$838,083

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$545K$1.1M2015 Drug cost: $289,971 (USD; Tot_Drug_Cst)2016 Drug cost: $172,295 (USD; Tot_Drug_Cst)2017 Drug cost: $127,734 (USD; Tot_Drug_Cst)2018 Drug cost: $102,128 (USD; Tot_Drug_Cst)2019 Drug cost: $148,228 (USD; Tot_Drug_Cst)2020 Drug cost: $195,585 (USD; Tot_Drug_Cst)2021 Drug cost: $167,365 (USD; Tot_Drug_Cst)2022 Drug cost: $494,148 (USD; Tot_Drug_Cst)2023 Drug cost: $672,285 (USD; Tot_Drug_Cst)2024 Drug cost: $1,089,569 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155011,215$289,971
20164961,167$172,295
20174751,131$127,734
20184521,043$102,128
20194381,121$148,228
20204531,139$195,585
20214771,233$167,365
20225081,254$494,148
20235371,407$672,285
20246311,805$1,089,569

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths558715$78
11102Biopsy of related skin growth, first growth511647$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,2231,722$61
17000Destruction of precancer skin growth, 1 growth9661,409$36
17003Destruction of precancer skin growth, 2-14 growths7895,469$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa292,324$602,820
Dupixent PenDupilumab391,512$207,672
Taltz AutoinjectorIxekizumab11392$98,176
TavaboroleTavaborole15445$5,585
Betamethasone DipropionateBetamethasone Dipropionate1494,366$5,490

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.47$1,098SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sandra Nash Hannegan, MD?

Tedicare shows public-source Medicare data for Sandra Nash Hannegan, MD (NPI 1710076294), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sandra Nash Hannegan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sandra Nash Hannegan, MD?

Sandra Nash Hannegan, MD is linked to LOWCOUNTRY DERMATOLOGY ASSOCIATES (billing NPI 1861518441) in the available physician profile data.

Does Sandra Nash Hannegan, MD have Open Payments data?

Sandra Nash Hannegan, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.